Phibro Animal Health (PAHC) Other Non-Current Liabilities (2013 - 2026)

Phibro Animal Health's (PAHC) quarterly Other Non-Current Liabilities came in at $1.2 million in Q1 2026, down 89.85% year-on-year from $12.2 million in Q1 2025, and down 88.21% quarter-over-quarter from $10.5 million in Q4 2025.

Phibro Animal Health (PAHC) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends

Phibro Animal Health's Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $1.2 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 89.85% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 89.85% decrease from a year earlier, with the FY2025 full-year figure at $79.3 million, up 1058.49% from the prior year.
  • Other Non-Current Liabilities declined to $1.2 million in Q1 2026 per PAHC's latest filing, from $10.5 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $79.3 million in Q2 2025 and bottomed at $1.2 million in Q1 2026.
  • The 5-year median for Other Non-Current Liabilities is $9.2 million (2022), against an average of $25.5 million.
  • Across the five-year window, Other Non-Current Liabilities sank 89.96% in 2023 and surged 1119.56% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $9.2 million in 2022, then dropped by 22.18% to $7.1 million in 2023, then surged by 65.0% to $11.8 million in 2024, then slipped by 11.05% to $10.5 million in 2025, then plunged by 88.21% to $1.2 million in 2026.
  • Per Business Quant, the three latest PAHC Other Non-Current Liabilities figures stand at $1.2 million (Q1 2026), $10.5 million (Q4 2025), and $79.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Phibro Animal Health 1.38 Bn 1.30 Bn 125.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.24 Mn
Dec 31, 2025 10.48 Mn
Sep 30, 2025 79.19 Mn
Jun 30, 2025 79.31 Mn
Mar 31, 2025 12.17 Mn
Dec 31, 2024 11.78 Mn
Sep 30, 2024 6.49 Mn
Jun 30, 2024 6.85 Mn
Mar 31, 2024 63.86 Mn
Dec 31, 2023 7.14 Mn
Sep 30, 2023 6.09 Mn
Jun 30, 2023 6.08 Mn
Mar 31, 2023 61.78 Mn
Dec 31, 2022 9.17 Mn
Sep 30, 2022 5.92 Mn
Jun 30, 2022 60.50 Mn
Mar 31, 2022 5.73 Mn
Dec 31, 2021 55.72 Mn
Sep 30, 2021 56.14 Mn
Jun 30, 2021 55.97 Mn